Albemarle’s Strategic Withdrawal and Capacity Expansion Drive Buy Rating Despite Earnings Projection Reduction
Blurbs

Albemarle’s Strategic Withdrawal and Capacity Expansion Drive Buy Rating Despite Earnings Projection Reduction

Albemarle (ALBResearch Report), the Basic Materials sector company, was revisited by a Wall Street analyst yesterday. Analyst Laurence Alexander from Jefferies maintained the rating on the stock to a Buy and gave it a $240.00 price target.

Laurence Alexander’s Buy rating for Albemarle (ALB) was predicated on a variety of factors. Firstly, Albemarle’s decision to withdraw its approximately $4.2 billion bid to acquire Liontown Resources was seen as a positive. This withdrawal underscores the company’s commitment to capital discipline and alleviates investor concerns about the company’s readiness to compromise their return on invested capital (ROIC) for large-scale asset acquisitions, particularly in light of uncertain short-term economic and lithium price forecasts.

The withdrawal should also reduce balance sheet risk, given the lack of clarity on the duration of this cycle and mid-cycle pricing. Moreover, Albemarle’s strategies for near-term capacity expansions to drive volume growth and enhance yields remain on schedule. Despite the recent reduction in earnings projections for 2023, 2024, and 2025 by 3%, 10%, and 9% respectively, due to weaker lithium pricing and anticipated destocking, the positive factors outweigh the negatives, leading to a Buy rating for ALB.

According to TipRanks, Alexander is a 4-star analyst with an average return of 2.4% and a 52.68% success rate. Alexander covers the Basic Materials sector, focusing on stocks such as Albemarle, Eastman Chemical, and Trinseo.

In another report released today, Wells Fargo also maintained a Buy rating on the stock with a $210.00 price target.

See today’s best-performing stocks on TipRanks >>

TipRanks tracks over 100,000 company insiders, identifying the select few who excel in timing their transactions. By upgrading to TipRanks Premium, you will gain access to this exclusive data and discover crucial insights to guide your investment decisions. Begin your TipRanks Premium journey today.

Albemarle (ALB) Company Description:

Albemarle Corp. is a specialty company, which engages in developing, manufacturing, and marketing of chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, transportation, pharmaceuticals, crop production, food-safety, and custom chemistry services. It operates through the following segments: Lithium, Bromine Specialties, and Catalysts. The Lithium segment engages in developing and manufacture of basic lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and value-added lithium specialties and reagents. The Bromine Specialties segment consists of bromine and bromine-based business includes products used in fire safety solutions and other specialty chemicals applications. The Catalysts segment contain two product lines: clean fuels technologies, which is primarily composed of hydro processing catalysts, and heavy oil upgrading that comprises of fluidized catalytic cracking catalysts and additives. The company was founded in 1993 and is headquartered in Charlotte, NC.

Read More on ALB:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
RUT
Russell 2000
TNX
10-Yr-Bond
Bitcoin

Popular Articles